ISPC
iSpecimen Inc.
There isn't enough reported data to score ISPC yet.
NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
ISPC Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Unavailable |
ISPC's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
ISPC PE Valuation
ISPC has no meaningful PE right now: it lost money over the past year.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
ISPC Forward outlook
There aren't enough analyst estimates for ISPC to show an outlook.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
ISPC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$53.64 | +$674.36 |
| Q1 2026 | -$69.46 | +$793.74 |
| Q4 2025 | -$91.20 | +$999.60 |
| Q3 2025 | -$663.20 | +$116.80 |
| Q2 2025 | -$728.00 | +$152.00 |
| Q1 2025 | -$863.20 | +$176.80 |
| Q4 2024 | -$1,090.80 | -$106.80 |
| Q3 2024 | -$780.00 | +$108.00 |
ISPC is still losing money, but far less than before: $53.64 per share over the past year, against $1,090.80 at its worst in late 2024.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the edge over ISPC on earnings quality, reporting a profit while its opponent remains loss making.
ISPC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $151.9K | -79% |
| Q1 2026 | $156K | -85% |
| Q4 2025 | $51.8K | -96% |
| Q3 2025 | $106.6K | -96% |
| Q2 2025 | $713.1K | -75% |
| Q1 2025 | $1.1M | -54% |
| Q4 2024 | $1.5M | -43% |
| Q3 2024 | $2.7M | -4.2% |
ISPC's revenue has slid since its 2022 peak: $151,940 last quarter, down 79% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -897% | -642 points |
| Q1 2026 | -1627% | -1472 points |
| Q4 2025 | -5193% | -4797 points |
| Q3 2025 | -2655% | -2591 points |
| Q2 2025 | -255% | -179 points |
| Q1 2025 | -155% | -24 points |
| Q4 2024 | -396% | -284 points |
| Q3 2024 | -64% | +15 points |
ISPC's operating margin was −897% last quarter, down 642 points from the same quarter a year ago.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO has the edge over ISPC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over ISPC on profitability, with a higher operating margin.
ISPC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$916.9K | +$2.7M |
| Q3 2025 | -$2M | -$941.6K |
| Q4 2024 | -$3.6M | -1137% |
| Q3 2024 | -$1.1M | +$545.5K |
| Q2 2024 | -$1.5M | +$159.8K |
| Q1 2024 | -$2.1M | +$752.1K |
| Q1 2023 | -$2.8M | -$1.5M |
NVO has the stronger cash trend. Its trailing FCF is down 14% versus its history, compared with ISPC at down 40%.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO still generates free cash flow, though less than at its 2026 peak: $7.3B over the past year.
ISPC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +308% | +1.1M shares |
| 1 year | +2301% | +1.3M shares |
| 3 years | +12322% | +1.4M shares |
ISPC has 1M diluted shares, up 2301% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $52,500 |
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over ISPC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
ISPC Net Leverage
ISPC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
ISPC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.7 | Oversold |
| Stochastic | 3.4 | Oversold |
ISPC's weekly RSI is 26 (oversold) and its Stochastic is 3 (oversold).
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
ISPC PE vs Healthcare Sector
ISPC has no meaningful PE right now: it lost money over the past year.
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
ISPC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.94 | 26% below |
| 20 week MA | $1.53 | 54% below |
| 50 week MA | $6.03 | 88% below |
| 100 week MA | $29.8 | 98% below |
| 200 week MA | $303.4 | 100% below |
ISPC is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over ISPC on trend strength, trading above more of its moving averages.
ISPC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $5,992.0 | $9,288.0 | +55% |
| 2022 | $9,288.0 | $1,056.0 | -89% |
| 2023 | $1,056.0 | $400.4 | -62% |
| 2024 | $400.4 | $112.4 | -72% |
| 2025 | $112.4 | $15.3 | -86% |
| 2026 YTD | $15.3 | $0.70 | -95% |
ISPC has finished four years in a row lower, and it's down 95% so far in 2026.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over ISPC on returns for 2026, with the stronger performance.